Low-dose regimen of interleukin-2 for metastatic renal carcinoma

Lancet. 1990 Jun 23;335(8704):1522-3. doi: 10.1016/0140-6736(90)93057-v.
No abstract available

Publication types

  • Letter

MeSH terms

  • Adult
  • Aged
  • Carcinoma, Renal Cell / drug therapy*
  • Carcinoma, Renal Cell / secondary
  • Drug Administration Schedule
  • Female
  • HLA Antigens / analysis
  • Humans
  • Interleukin-2 / administration & dosage*
  • Kidney Neoplasms / drug therapy*
  • Kidney Neoplasms / secondary
  • Leukocyte Count / drug effects
  • Lymphocyte Activation / drug effects
  • Male
  • Middle Aged

Substances

  • HLA Antigens
  • Interleukin-2